Development of retinal biomarkers for Alzheimer's disease

The retina has received increasing intention as possible non‐invasive diagnostic biomarker for (preclinical) Alzheimer’s disease (AD). Several studies suggest changes in retinal layer thickness or vasculature in patients with AD. Here, we aim to discriminate (preclinical) Alzheimer’s disease from controls using three retinal imaging modalities in a multimodal prediction model.